The effect of trastuzumab combined with TP regimen on PAI-1, HER2 receptors and lymphocyte subsets in breast cancer patients

FANG Xun; LIU Beibei; ZHU Qilong; JIAO Hao

doi:10.13683/j.wph.2025.07.008

World Clinical Drugs, Volume. 46, Issue 7, 675(2025)

The effect of trastuzumab combined with TP regimen on PAI-1, HER2 receptors and lymphocyte subsets in breast cancer patients

FANG Xun¹, LIU Beibei¹, ZHU Qilong¹, and JIAO Hao²

Author Affiliations

¹Department of Pharmacy, Yingshang County People's Hospital, Yingshang 236200, Anhui Province, China

²Department of Pharmacy, the First Affiliated Hospital of Wannan Medical College/Yijishan Hospital, Wuhu 241001, Anhui Province, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

FANG Xun, LIU Beibei, ZHU Qilong, JIAO Hao. The effect of trastuzumab combined with TP regimen on PAI-1, HER2 receptors and lymphocyte subsets in breast cancer patients[J]. World Clinical Drugs, 2025, 46(7): 675

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Mar. 2, 2025

Accepted: Aug. 26, 2025

Published Online: Aug. 26, 2025

The Author Email:

DOI:10.13683/j.wph.2025.07.008

Topics